Tesamorelin is a stabilized analog of full-length GHRH (1-44) studied for growth-hormone-axis signalling and visceral-fat-related metabolic research.
Tesamorelin is a synthetic analog of human growth hormone-releasing hormone that keeps all 44 amino acids of native GHRH and carries a trans-3-hexenoyl group at its N-terminus. This modification is studied for improved stability against enzymatic degradation, allowing research into sustained GHRH receptor engagement.
Research on tesamorelin examines the stimulation of endogenous, pulsatile growth-hormone release, downstream IGF-1 signalling and lipid metabolism, with particular interest in visceral adipose tissue in preclinical and clinical research settings.
Studied for GHRH receptor activation and endogenous growth-hormone release in research models.
Investigated for effects on visceral fat and body-composition markers in metabolic research.
Examined for downstream IGF-1 signalling following GHRH receptor stimulation.
Characterized for its N-terminal hexenoyl modification, which improves resistance to enzymatic cleavage.
Bring the vial (10 mg · 20 mg) and bacteriostatic water to room temperature.
Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.
Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.
Studied together combining GHRH-receptor and GH-secretagogue pathways in growth-axis research models.
Explored in research examining GHRH signalling alongside lipolysis-focused GH-fragment models.
Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.
Tesamorelin is a synthetic analog of full-length GHRH (1-44) with an N-terminal trans-3-hexenoyl group. It is studied for growth-hormone-axis signalling in research.
CJC-1295 is based on the shortened GHRH 1-29 sequence, while tesamorelin keeps all 44 amino acids of native GHRH and is stabilized by an N-terminal modification instead.
It is studied in the context of GHRH receptor activity, pulsatile growth-hormone release, IGF-1 signalling and visceral-fat-related metabolic research models.
You must be at least 21 years old to enter this website.
By clicking "Confirm & Enter", you confirm that you are 21 years of age or older and understand that all products sold on this website are intended for research purposes only.
